The U.S. legal marijuana market continues to accelerate, reaching $20 billion in sales so far in 2025. Per capita data shows Michigan in the lead, while smaller markets such as Montana and New Mexico are outpacing larger states in consumer spending. Using September’s state sales figures and the most recent U.S. Census data, Michigan leads …
Category: Miscellaneous
Oct 12 2025
September Cannabis Sales Hit $2.34 Billion in the U.S., Pushing 2025 Total to $20 Billion
Legal cannabis sales in the United States hit a yearly high of $2.34 billion in September, according to data from state regulators, cannabis commissions, and the research firm Headset. The total represents an increase from the $2.27 billion sold in August, pushing 2025’s year-to-date sales to roughly $20 billion. The figure reflects sales from 22 …
Oct 12 2025
U.S. Congress: Legislation to End Cannabis Prohibition Nationwide and Allow Expungements Now Sponsored by Lawmakers From 26 States and D.C.
Legislation to federally end marijuana prohibition and allow for expungements continues to gain momentum in the U.S. House, with sponsors and cosponsors now spanning 26 different states and the District of Columbia. The measure, which would remove marijuana from the Controlled Substances Act and create a process for clearing past convictions, has drawn wide-ranging support. …
Oct 10 2025
Global Marijuana Market Projected to Grow From $39 Billion in 2024 to $151 Billion in 2033
The worldwide marijuana industry is forecast to climb from $39.1 billion in 2024 to more than $151 billion by 2033, according to a new report by Research and Markets. That represents an annual growth rate of over 16%, driven largely by expanding legalization, medical adoption, and shifting consumer preferences.
Oct 09 2025
Tilray Brands Posts $210 Million in Quarterly Revenue, Returns to Profitability
Tilray Brands has reported record first quarter fiscal 2026 results, achieving $210 million in net revenue and posting net income of $1.5 million. The company says the performance underscores its focus on profitability and operational efficiency, with adjusted EBITDA climbing 9% year-over-year to $10.2 million. Cash flow from operations also improved significantly, narrowing to a …
Oct 07 2025
The Top 10 States for Cannabis Tourism
As marijuana legalization continues to expand across the United States, certain states have emerged as leading destinations for cannabis tourism. These states not only allow legal sales to adults, but also offer unique attractions, cultural experiences, and thriving marijuana industries that draw in travelers from across the country and beyond. These states stand out for …
Oct 03 2025
The Tax Rate for Recreational Marijuana in Every Legal State as of October 2025
While 24 states have legalized recreational cannabis as of October 2025, with 23 allowing licensed sales, the way each approaches taxation differs widely. Some states levy a flat excise tax, others apply sales taxes on top, and several use weight- or potency-based systems. With that in mind, below is a breakdown of the current tax …
Oct 01 2025
U.S. Congress: Here’s Every Lawmaker Sponsoring Legislation to End Cannabis Prohibition Nationwide
Here’s a complete list of every member of the United States Congress currently sponsoring legislation to end cannabis prohibition. The Marijuana Opportunity Reinvestment and Expungement (MORE) Act would end federal prohibition by fully descheduling marijuana, in addition to several other provisions such as allowing expungements of past convictions, while the STATES 2.0 Act would stop …
Sep 30 2025
The Body’s Cannabis Network: A Deep Dive into the Endocannabinoid System
The endocannabinoid system has gained increased attention in recent days following a social media post made by President Trump. In this article, we break down the system and explain what it is, how it works, and why marijuana interacts with it so effectively. The endocannabinoid system has been described by scientists as the body’s quiet …
Sep 29 2025
20 Cannabis Clinical Trials Published in the Past 12 Months
The past 12 months have been huge for cannabis research, with hundred of studies and dozens of rigorously designed clinical trials published across a wide range of medical fields. From chronic pain and neurodegeneration to psychiatric disorders and oncology, researchers are testing cannabis and its compounds in ways that were once limited by regulatory barriers. …


